Related by context. All words. (Click for frequent words.) 74 Valortim R 73 Valortim ® 73 Anthim 70 Protexia R 70 NEUMUNE 69 oral prodrug 69 Traficet EN 68 Protectan CBLB# 68 Protexia ® 68 SparVax TM 67 AVP #D# 67 RiVax 67 ganetespib 67 PRTX 67 Acute Radiation Syndrome ARS 67 favorable pharmacokinetic profile 67 CBLB# 67 ASONEP 66 omega interferon 66 Restanza 66 INCB# [001] 66 IMA# 66 forodesine 66 OncoVEX GM CSF 65 Cethromycin 65 PXD# 65 preclinical efficacy 65 Azedra 65 R#/MEM # 65 OHR/AVR# 65 AEOL # 65 CBLC# 65 Altastaph 65 CoFactor 65 TOLAMBA 65 HQK 65 GeoVax vaccine 65 H#N# VLP vaccine 65 ARIKACE 65 Valortim TM 64 vidofludimus 64 CR# vcMMAE 64 MAXY G# 64 influenza VLP vaccine 64 CCX# 64 RiVax TM 64 ROTARIX 64 Sym# 64 raxibacumab 64 velafermin 64 DXL# 64 HuMax EGFr 64 Phase 2a trial 64 riociguat 64 XmAb# 64 Xanafide 64 NGX# 63 ALN VSP 63 therapeutic monoclonal antibody 63 Golimumab 63 HuMax CD# 63 PRT# 63 SparVax ™ 63 TKM Ebola 63 Homspera 63 GAMMAGARD 63 bafetinib 63 HCV protease inhibitor 63 mertansine 63 HGS ETR2 63 recombinant subunit vaccine 63 VLP vaccine 63 Radilex 63 LymphoStat B 63 OncoVEX 63 Amigal 63 NP2 Enkephalin 63 Allovectin 7 R 63 Phase Ib study 63 torezolid phosphate 63 IND submission 63 tezampanel 63 ABthrax 63 RGB # 63 rBChE 63 eniluracil 63 atacicept 63 KNS # 63 obatoclax 63 Thiovir 63 velafermin belinostat 63 Synavive 63 HuLuc# 63 vosaroxin 63 vivo efficacy 63 HuMax CD4 63 nanoviricides 63 TOCOSOL Paclitaxel 63 Vaxfectin 63 Triolex 63 pharmacokinetic PK study 63 GLP toxicology studies 62 Alinia 62 ALN TTR 62 pDNA vaccine 62 RDEA# 62 oral antiviral 62 YONDELIS 62 talactoferrin 62 rilonacept 62 radezolid 62 ELND# 62 CEQ# 62 telaprevir VX 62 CIMZIA TM 62 PEG SN# 62 antibody MAb 62 nitazoxanide 62 ONCONASE 62 Tarvacin TM 62 Elusys 62 PLX cells 62 phase IIa clinical 62 bevirimat 62 fosbretabulin 62 preclinical studies 62 immune modulatory 62 Multimeric 62 CGEN # 62 TG# [003] 62 Tarvacin 62 Capesaris 62 Ceflatonin 62 OXi# 62 otelixizumab 62 PEG Interferon lambda 62 pafuramidine 62 Phase 1b trial 62 solithromycin 62 oral ridaforolimus 62 Phase IIB 62 HGS ETR1 62 enzastaurin 62 PS# [001] 62 Virulizin ® 62 Chemophase 62 Panzem R 62 CD# monoclonal antibody 62 CRMD# 62 Fx #A 62 GRNVAC1 62 huC# DM4 62 pharmacokinetic PK 62 iSONEP 62 Phase 2a clinical trials 62 CRLX# 62 Cytolin ® 62 anticancer agent 62 Alferon N 62 CA4P 62 potent antiviral 61 BNC# 61 oral FTY# 61 Tyrima 61 BrachySil 61 PROCHYMAL 61 BioVant 61 Bezielle 61 APOPTONE 61 pharmacodynamic PD 61 ATL# [001] 61 adenoviral vectors 61 cMET 61 Reolysin 61 HCV protease 61 HspE7 61 orally bioavailable 61 cilengitide 61 ospemifene 61 rPA 61 nucleotide analog 61 viral kinetics 61 MAGE A3 ASCI 61 IMVAMUNE R 61 investigational monoclonal antibody 61 Interferon alpha 61 depsipeptide 61 rPA anthrax vaccine 61 TRIOLEX 61 antiviral efficacy 61 vivo validation 61 preclinically 61 TPI ASM8 61 Ophena TM 61 Phase 1a clinical 61 lucinactant 61 CCR9 antagonist 61 NEUGENE 61 rindopepimut 61 Archexin 61 MEK inhibitor RDEA# 61 HCD# [002] 61 Preclinical studies 61 OMNARIS HFA 61 EndoTAG TM -1 61 evaluating tivozanib 61 Exherin TM 61 liposomal formulation 61 Ebola SNALP 61 Arikace 61 Surfaxin LS 61 TransVax ™ 61 PROVENGE sipuleucel T 61 BiovaxID 61 tanespimycin 61 DermaVir 61 Symadex 61 MT#/MEDI-# 61 hGH CTP 61 angiogenesis inhibitor 61 IRX 2 61 methylnaltrexone 61 Aurexis 61 TELCYTA 61 Curaxin CBLC# 61 ProSavin 61 ANAVEX #-# [001] 61 DAVANAT 61 CIMZIA ™ 61 Universal Flu Vaccine 61 Protexia 61 investigational humanized monoclonal antibody 61 ZYBRESTAT 61 iroxanadine 61 GLYX 61 Alocrest 61 ATL/TV# 61 systemically administered 61 ALN RSV# 61 AEG# 61 #D#C# 61 PKC# 61 butyrylcholinesterase 61 nanoviricide 61 MGd 61 omacetaxine 61 Factor VIIa 61 FluCide 61 iclaprim 61 OvaRex ® MAb 61 Onconase 60 pharmacokinetic studies 60 cystinosis patients 60 humanized anti 60 Bicifadine 60 trastuzumab DM1 T DM1 60 Pralatrexate 60 Prodarsan ® 60 TACI Ig 60 CYT# 60 CMV vaccine 60 OvaRex R 60 preclinical toxicology 60 BAL# [001] 60 LC#m# 60 BEXXAR 60 cobiprostone 60 IMVAMUNE TM 60 Phase Ib clinical 60 FluINsure 60 PCK# 60 ImmunoVEX HSV2 60 IDX# 60 Zalypsis 60 immunomodulatory 60 RAV# 60 RhuDex ® 60 MET amplification 60 Tezampanel 60 tolerability profiles 60 Azixa 60 Lenocta 60 Viprovex 60 ALN TTR# 60 GED aPC 60 ENMD # 60 anti EGFR antibody 60 pomalidomide 60 orBec 60 CCR5 mAb 60 preclinical 60 pharmacodynamic profile 60 amrubicin 60 immune modulating 60 Fibrillex TM 60 IIa trial 60 UPLYSO 60 biodefense countermeasure 60 mapatumumab 60 phase Ib 60 custirsen 60 oral methylnaltrexone 60 Cloretazine R VNP#M 60 MVA BN R 60 LymphoStat B TM 60 Phase Ib clinical trials 60 Panzem 60 StaphVAX R 60 entinostat 60 alagebrium 60 PDE4 inhibitor 60 Bendavia 60 proteasome inhibitor 60 Serdaxin 60 Omacetaxine 60 RiVax ™ 60 Catena ® 60 DepoVax TM 60 Tarceva TM 60 laquinimod 60 anti amnesic 60 maximally tolerated dose 60 GRNCM1 60 posaconazole 60 Locteron 60 OncoVex 60 INGN 60 virus HCV protease inhibitor 60 MYDICAR ® 60 serum antibody 60 ELACYT 60 histone deacetylase inhibitor 60 BiTE antibody 60 phase IIb clinical 60 attenuated strain 60 mcg dose 60 GRN# 60 oncolytic virus 60 VIR# 60 Aerosurf 60 PSN# [002] 60 erlotinib Tarceva ® 60 daptomycin 60 Cardio Vascu Grow 60 eltrombopag 60 tafamidis 60 anti CD3 monoclonal 60 elotuzumab 60 nonclinical studies 60 cannabinor 59 Trofex 59 AzaSite Plus 59 MAXY alpha 59 induces antibodies 59 RNAi therapeutic targeting 59 Phase Ib II 59 A3 adenosine receptor 59 pralatrexate 59 anti leukemic 59 oral bioavailability 59 Phase #b/#a clinical 59 IL# PE#QQR 59 PLK1 SNALP 59 immunotherapeutic 59 AVN# [001] 59 BAL# [002] 59 PEGPH# 59 MGCD# [001] 59 NeuroVax TM 59 Spiegelmer ® 59 systemic RNAi therapeutic 59 decitabine 59 Imprime PGG 59 LY# [003] 59 ataluren 59 lintuzumab 59 CORT # 59 oritavancin 59 Plicera 59 immunomodulator 59 Bavituximab 59 dacetuzumab 59 targeting CD# 59 #ME# 59 ganaxolone 59 CTAP# Capsules 59 Civacir 59 SNT MC# 59 ADAGIO study 59 Aliskiren 59 PSMA ADC 59 EDEMA3 trial 59 tipifarnib 59 celgosivir 59 Lovaxin C 59 PHX# 59 JVRS 59 pemetrexed Alimta 59 Phase 2b trial 59 Vilazodone 59 neuroprotective properties 59 Pafuramidine 59 CERVARIX 59 Actilon 59 nanoviricide drug 59 Quinamed 59 MyVax R 59 Ampligen R 59 TELINTRA 59 rALLy clinical trial 59 bortezomib Velcade 59 JAK inhibitor 59 urocortin 2 59 Fodosine 59 DepoVax 59 thymalfasin 59 Telatinib 59 prophylactic vaccine 59 orally dosed 59 acetonide FA 59 cariprazine 59 SAR# [004] 59 Guanilib 59 PANVAC VF 59 chemotherapy induced neutropenia 59 DermaVir Patch 59 Tamibarotene 59 ANAVEX #-# [003] 59 Phase IIIb clinical 59 GMX# 59 Phase 1a 59 Androxal TM 59 ApoB SNALP 59 IMVAMUNE ® 59 TRO# 59 Revimmune 59 OncoGel 59 dose cohort 59 immunotherapeutic vaccine 59 Epratuzumab 59 CD# CEA 59 Neuradiab 59 PolyActive ® 59 IL #E 59 PREVENAR 59 elacytarabine 59 Cloretazine ® 59 INT# [002] 59 Aplidin 59 voreloxin 59 Saforis 59 small molecule defensin 59 apricitabine ATC 59 antiviral activity 59 ulimorelin 59 lesinurad 59 phase IIa 59 Factor IX 59 Onalta 59 intranasal formulation 59 lomitapide 59 PROSTVAC TM 59 ZFP Therapeutic 59 investigational immunotherapy 59 farletuzumab 59 PNP inhibitor 59 axitinib 59 subcutaneous formulation 59 Sphingomab 59 Phase IIb trials 59 JAK2 inhibitor 59 neuraminidase inhibitor 59 BioNumerik 59 antiviral potency 59 IgG1 antibody 59 neratinib 59 Nanobody 59 Elotuzumab 59 CDDO Im 59 HGS ETR1 mapatumumab 59 Exelixis compounds 59 Phase 2a 59 samalizumab 59 pradefovir 59 romidepsin 59 IMGN# 59 HuCAL antibodies 59 GALNS 59 Phase #b/#a 59 pan HDAC inhibitor 59 AZILECT ® 59 trodusquemine 59 cetuximab Erbitux ® 59 pharmacokinetic PK profile 59 SRT# [003] 59 NovaBay Aganocide compounds 59 Inhalation Solution 59 Zerenex 58 next generation URAT1 58 siRNA therapeutic 58 budesonide foam 58 ChronVac C ® 58 AMPK activators 58 milatuzumab 58 VitiGam 58 Carfilzomib 58 valopicitabine 58 tolerability profile 58 TriRima 58 somatostatin analogue 58 menadione 58 ALN PCS 58 RNAi Therapeutic 58 alvespimycin 58 uric acid lowering 58 CANCIDAS 58 sunitinib Sutent ® 58 AeroLEF TM 58 lenalidomide Revlimid R 58 Phase Ib 58 MAA submission 58 HBV vaccine 58 EndoTAG TM 58 investigational antibody 58 Radezolid 58 cethromycin 58 triphendiol 58 novel VDA molecule 58 Trofex TM 58 Panzem R NCD 58 MAP# 58 Allovectin 7 58 personalized immunotherapy 58 oncolytic 58 ketolide antibiotic 58 baminercept 58 NPC 1C 58 JAK3 58 Palifosfamide 58 DCVax ® 58 PD LID 58 BLA submission 58 MORAb 58 Kahalalide F 58 MyVax ® 58 Onalta ™ 58 selective androgen receptor modulator 58 PEGylated 58 oral rivaroxaban 58 rFIXFc 58 CTCE 58 Tesetaxel 58 XL# XL# 58 vascular disrupting agent 58 ONCONASE R 58 Kevetrin 58 BRIM2 58 StaphVAX 58 SinuNase TM 58 liprotamase 58 Vandetanib 58 deforolimus 58 Proxinium TM 58 mifamurtide 58 tamibarotene 58 Omacetaxine mepesuccinate 58 Phase 2a clinical 58 phase IIb trial 58 potent cytotoxic 58 dexanabinol 58 DPX Survivac 58 talabostat 58 Phase IIb clinical trials 58 vemurafenib 58 Phase IIa clinical 58 GFT# 58 cancer immunotherapies 58 multi kinase inhibitor 58 intranasal delivery 58 ATryn R 58 SCH # 58 RSD# 58 highly immunogenic 58 tezampanel NGX# 58 CLORETAZINE TM VNP#M 58 delafloxacin 58 Alzhemed TM 58 NVA# 58 isavuconazole 58 ISIS # 58 IIa clinical 58 Staphylococcus aureus Polysaccharide Conjugate 58 Ramoplanin 58 inhalational anthrax 58 anidulafungin 58 teduglutide 58 Solazed TM 58 oxaliplatin Eloxatin 58 immunomodulatory properties 58 immune stimulatory 58 sipuleucel T 58 Phase Ia 58 Zoraxel 58 investigational protease inhibitor 58 R#/MEM 58 Anticalin ® 58 XYNTHA 58 monoclonal antibody mAb 58 NEBIDO 58 BARACLUDE R 58 Nanobody ® 58 IMC #B 58 Resten NG 58 AAG geldanamycin analog 58 tremelimumab 58 Phase 1b 58 oral deforolimus 58 S/GSK# 58 masitinib 58 rhITF 58 T#I [002] 58 administered subcutaneously 58 tecarfarin 58 isatoribine 58 vapreotide acetate 58 ETEC vaccine 58 Ketotransdel 58 Cotara 58 XP# XP# 58 registrational 58 MYCAMINE 58 Cinryze ™ 58 Tavocept 58 huN# DM1 58 CD# antibody [001] 58 zileuton 58 Dacogen injection 58 optimal dosing regimens 58 rhThrombin 58 Cloretazine 58 ponatinib 58 AP# [003] 58 TransVax TM 58 HGS# 58 midstage trials 58 GSK# [001] 58 targeted antifolate 58 TB4 58 adecatumumab 58 pertuzumab 58 pexiganan 58 Shigamabs ® 58 Phenoptin 58 XL# inhibits 58 Pegasys ® 58 Apoptone 58 LHRH antagonists 58 intratumoral injection 58 targeted radiotherapeutic 58 FavId 58 pharmacodynamic 58 volociximab 58 HCV polymerase 58 investigational HCV polymerase 58 HSP# inhibitor 58 ON #.Na 58 aclidinium 58 therapeutic monoclonal antibodies 58 NEUGENE antisense 58 Vacc 4x 58 glufosfamide 58 TLR9 agonist 58 trabectedin 58 Phase 2b Clinical Trial 58 nicotinic alpha 7 58 liposomal doxorubicin 58 Neo Kidney Augment 58 phase IIb 58 OMAPRO 58 LEX System 58 anti CD# antibodies 58 oral picoplatin 57 tipranavir 57 torezolid 57 drug ISA# 57 GGF2 57 EVIZON TM 57 paclitaxel poliglumex 57 anticancer compound 57 phosphatidylserine PS targeting 57 human monoclonal antibody 57 canakinumab 57 HepaGam B 57 L MTP PE 57 LymphoStat B belimumab 57 non nucleoside HCV 57 ACZ# 57 Chimigen TM 57 Copegus ribavirin 57 cytoprotective 57 Allovectin 7 ® 57 TKM PLK1 57 Unit Dose Budesonide 57 CYT# potent vascular disrupting 57 faropenem 57 IGF 1R inhibitor 57 NXL# 57 Xcytrin R 57 Phase 1b clinical 57 PROMACTA 57 CCR5 antagonist 57 anthrax monoclonal antibody 57 Bioral 57 Preclinical studies suggest 57 refractory gout 57 Icatibant 57 reslizumab 57 Dalbavancin 57 Personalized Immunotherapy 57 teriflunomide 57 rhMBL 57 nalbuphine ER 57 ADVEXIN 57 bactericidal activity 57 Modified Vaccinia Ankara MVA 57 teplizumab 57 anticoagulant reversing agent 57 JAK inhibitors 57 GLPG# 57 Angiolix 57 Ceftaroline 57 ongoing Phase 1b 57 CINTREDEKIN BESUDOTOX 57 Phase 2b study 57 cGMP manufacture 57 MOZOBIL 57 protein kinase inhibitor 57 humanized monoclonal antibody 57 SparVax 57 Menerba 57 Meets Primary Endpoint 57 TREANDA 57 Ceflatonin R 57 bevasiranib 57 Belerofon 57 TLR7 57 trastuzumab Herceptin R 57 PEG PAL 57 sd rxRNA 57 adalimumab Humira 57 Amplimexon 57 MEK inhibitor 57 Proellex TM 57 live attenuated vaccines 57 docetaxel Taxotere R 57 anticancer activity 57 Clolar ® 57 Aflunov 57 ACTEMRA 57 antitumoral 57 plasma kallikrein inhibitor 57 chronic HCV infection 57 oncolytic viruses 57 Myocet 57 docetaxel Taxotere ® 57 Monoclonal Antibody 57 alpha#beta# integrin 57 bendamustine 57 IAP inhibitor 57 AAV vector 57 IMC A# 57 adecatumumab MT# 57 SUTENT 57 Triapine R 57 investigational therapies 57 histamine dihydrochloride 57 oxymorphone ER 57 non nucleoside 57 Nanobodies ® 57 polymerase inhibitor 57 Alpharadin 57 Virulizin R 57 Phase IIa clinical trials 57 Imvamune 57 ridaforolimus 57 SynCon 57 Bortezomib 57 ZD# [001] 57 Twinrix 57 cidofovir 57 Dyloject TM 57 brivaracetam 57 Viprinex 57 QLT# 57 Perifosine 57 Tolerx 57 BENLYSTA ® 57 human IgG1 monoclonal 57 bevacizumab Avastin ® 57 hormone LHRH antagonist 57 Viral Immunotherapy platform 57 novel anticancer 57 inhaled formulation 57 ThermoDox ® 57 VivaGel TM 57 Listeria vaccine 57 Bevirimat 57 HuMax TAC 57 Epothilones 57 BAY #-# 57 eTag assays 57 XOMA 3AB 57 BZL# 57 OxBC 57 davunetide intranasal AL 57 Vaxfectin ® 57 EP #R 57 HCV polymerase inhibitor 57 DAVANAT ® 57 RG# [001] 57 HCV protease inhibitors 57 Cimzia TM 57 Maribavir 57 Blinatumomab 57 anti angiogenic agent 57 dexpramipexole 57 trastuzumab Herceptin 57 TroVax 57 ixabepilone 57 TRX1 57 Crofelemer 57 IMP# 57 CAMPATH 57 CYC# 57 Phase #b/#a trial 57 Talabostat 57 rNAPc2 57 leading oral taxane 57 systemic immunosuppressive drugs 57 Hyphanox 57 anticancer therapy 57 RIGScan CR 57 Mipomersen 57 Curaxin 57 Aplidin R 57 miltefosine 57 MultiStem 57 clinical pharmacology studies 57 RNAi therapeutic 57 anticancer therapies 57 imetelstat 57 TKM ApoB 57 selective orally bioavailable 57 FOLOTYN ® 57 alvimopan 57 ProMune 57 confirmatory Phase III 57 Stedivaze 57 Phase IIa trial 57 TRX# 57 ILLUMINATE 57 Intravail R 57 Microplasmin 57 #I TM# 57 ThGRF 57 inactivated vaccine 57 synthetic retinoid 57 Cethrin 57 APTIVUS 57 oral taxane 57 EOquin TM 57 diabetic neuropathic pain 57 CD4 monoclonal antibody 57 GelVac TM 57 C1 INH 57 vascular disrupting agents 57 receptor tyrosine kinase inhibitor 57 Aflibercept 57 TORISEL 57 investigational oral hepatitis C 57 tgAAC# 57 denufosol 57 KL4 surfactant 57 Neugene 57 FDA Approvable Letter 57 humanized antibodies 57 tkRNAi 57 molecular imaging radiopharmaceutical 57 PNT# 57 PEGylated interferon 57 PEGylated Fab fragment 57 MT# MEDI 57 Aeroquin 57 ZOLINZA 57 ACTEMRA TM 57 multicenter Phase II 57 anti CD# antibody 57 non nucleoside inhibitor 57 AEGR 57 antibiotic resistant bacterial infections 57 NOX E# 57 antisense drug 57 novel histone deacetylase 57 imatinib Gleevec ® 57 panitumumab Vectibix 57 Phase IIb Trial 57 Onrigin 57 lead Aganocide compound 57 virosome 57 Ampligen ® 57 Juvaris 57 Solulin 57 Lpathomab 57 antitumor activity 57 Vitaxin 57 Vaxfectin TM adjuvant 57 Poly ICLC 57 nanopharmaceutical 57 Diamyd ® 57 IMPDH inhibitor 57 BrachySil TM 57 pharmacokinetic profile 57 immunogenicity 57 GTC recombinant human 57 mitogen activated ERK kinase 57 Prodarsan R 57 VAPRISOL 57 amikacin 57 PROSTVAC VF 57 ZK EPO 57 sunitinib malate 57 adenovector 57 anti CD# monoclonal 57 cancer vaccine Norelin 57 HepeX B TM 56 GAP #B# 56 prophylactic vaccines 56 ATL# [002] 56 4CMenB 56 IFN Beta 56 Bioral Amphotericin B 56 KRN# 56 registrational trial 56 trivalent influenza vaccine 56 Hsp# Inhibitor 56 edoxaban 56 Prosaptide 56 LUVENIQ 56 INCB# [002] 56 ANA# 56 Tasimelteon 56 Chrysalin 56 Viramidine 56 Perforomist ™ Inhalation Solution 56 Ampligen r 56 BLA filing 56 REOLYSIN ® 56 Laquinimod 56 Pradefovir 56 elvucitabine 56 biodistribution 56 Elesclomol 56 recurrent glioblastoma multiforme 56 Genasense ® oblimersen 56 GRN#L 56 neutralizing antibody 56 Cerashield 56 protective antigen 56 Gleevec resistant 56 tiapamil 56 OMP #M# 56 GATTEX TM 56 replicon 56 indibulin 56 ACAM# 56 G#DT 56 IND enabling 56 T Pred 56 Ostarine 56 administered intranasally 56 Japanese Encephalitis vaccine 56 Vidofludimus 56 PENNVAX B 56 pharmacodynamic properties 56 Seliciclib 56 Sapacitabine 56 MVA BN 56 immunotoxins 56 RhuDex 56 RAPAFLO 56 Neulasta ® 56 palifosfamide 56 IPLEX 56 DORIBAX 56 cardio renal 56 Immunotherapeutic 56 Poly ICR 56 Tarvacin Anti Viral 56 NIH NIAID